Stephen Furst, who played naive fraternity pledge Flounder in the hit movie "Animal House," has died of complications from diabetes, his family said Saturday. Furst was 63.
NYS Entity Status
NYS Filing Date
OCTOBER 22, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - FURST CLASS & COUTINHO CONSULTING INC.
AROUND THE WEB
- Stephen Furst, Flounder in 'Animal House,' Dies at 63
By THE ASSOCIATED PRESS - Sunday Jun 18, 2017
- Ryder Trucks Launches Campaign With 'Inc.'
Tuesday Sep 19, 2017
"The campaign underscores how truck owners are essentially dumping cash all over America's highways from all the hidden costs required in maintaining a private fleet," Ryder's Karen Jones tells"Marketing Daily."
- At Walmart Academy, Training Better Managers. But With a Better Future?
By MICHAEL CORKERY - Tuesday Aug 8, 2017
A new program for store supervisors and department managers may make them better employees but may not help them reach the middle class.
- Snap stock is tanking again after user growth slows down
By Christopher Zara - Thursday Aug 10, 2017
This is not good news for Snap Inc. The parent company of Snapchat saw its shares tumble in after-hours trading today after it reported disappointing user growth in its Q2 2017 earnings. It’s only the second earnings report since Snap went public in March, and hopes for a turnaround are deteriorating. Shares fell to $11.90 after … Continue reading “Snap stock is tanking again after user growth slows down”
This is not good news for Snap Inc. The parent company of Snapchat saw its shares tumble in after-hours trading today after it reported disappointing user growth in its Q2 2017 earnings. It’s only the second earnings report since Snap went public in March, and hopes for a turnaround are deteriorating. Shares fell to $11.90 after hours, an all-time low. Snap debuted on the NYSE at $17 a share. It fell below that price a month ago and hasn’t recovered. The company reported daily active users growth of 7 million to 173 million total, but analysts were expecting about 8 million new users, CNBC reports. You can check out Snap’s full earnings release here. We’ll have more after the call later today.
- Cancer drug research moving fast in immunotherapy field
By Michelle Fay Cortez - Tuesday Sep 5, 2017
The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.
- NO CLASS NY prof’s tweet: I like ‘teaching future dead cops’
By email@example.com (Fox News Online) - Friday Sep 15, 2017